Financials
- Market Capitalization 7.26 B
- Employee 418
- Founded 2018
- CEO N/A
- Website www.mirumpharma.com
- Headquarter Delaware, United States
- FIGI BBG00MH7T2M7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1065 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 60.94 USD | -3.94% | -3.73% | +17.99% | +53.71% | 7.62 B USD | ||
| 1081 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.49 USD | -0.84% | -4.88% | +22.64% | -2.56% | 7.37 B USD | ||
| 1156 | SRRK Scholar Rock Holding Corporation - Common Stock | 54.70 USD | -3.54% | -1.48% | +22.34% | +82.21% | 6.55 B USD | ||
| 1159 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.72 USD | -1.74% | +10.83% | +30.18% | +66.02% | 6.55 B USD |
Frequently asked questions about Mirum Pharmaceuticals, Inc. - common stock
What is the Mirum Pharmaceuticals, Inc. - common stock stock price today?
The current price of Mirum Pharmaceuticals, Inc. - common stock (MIRM) is 119.04. Over the past 24 hours, the stock has changed by -2.53%. Follow the MIRM chart for real-time price dynamics.
What is the stock ticker of Mirum Pharmaceuticals, Inc. - common stock?
Mirum Pharmaceuticals, Inc. - common stock trades under the ticker MIRM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Mirum Pharmaceuticals, Inc. - common stock stock going up?
MIRM has changed by -3.69% over the last week, +19.21% over the last month, and +69.74% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Mirum Pharmaceuticals, Inc. - common stock net income for the last quarter?
Mirum Pharmaceuticals, Inc. - common stock reported net income of -790.15 M for the last quarter. The previous quarter showed -5.73 M, which means net income changed by -13689.79%.
How many employees does Mirum Pharmaceuticals, Inc. - common stock have?
As of the latest available data, Mirum Pharmaceuticals, Inc. - common stock has 418 employees. Workforce size can provide additional context about the company's scale and operations.
What is Mirum Pharmaceuticals, Inc. - common stock EBITDA?
Mirum Pharmaceuticals, Inc. - common stock EBITDA is -782.59 M, and its EBITDA margin is -489.48%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Mirum Pharmaceuticals, Inc. - common stock stock?
You can buy Mirum Pharmaceuticals, Inc. - common stock (MIRM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Mirum Pharmaceuticals, Inc. - common stock stock?
Investing in Mirum Pharmaceuticals, Inc. - common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MIRM chart and related analysis on metatrader.com as part of your research.